HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.

AbstractOBJECTIVES:
To evaluate the usefulness of levetiracetam (LEV) for the treatment of tics in patients with Tourette syndrome (TS) by means of a prospective, open-label, 12-week study.
MATERIAL AND METHODS:
Twenty-nine patients with TS who received LEV to control their tics were admitted to the study. The authors recorded the following variables: initial status (Yale Global Tic Severity Scale - YGTSS - and the scale of Modified Clinical Global Impression -MCGI), the clinical status at 3 months using the same scales, and clinical/medical impression of improvement.
RESULTS:
The mean age of the patients studied was 12 years; 25 males (86%) and 4 females (14%). Participants received 800-2000 mg/day of LEV. Of the 29 patients, 21 children (72%) improved according to YGTSS and MCGI scores. Mean YGTSS Total Tic Score at baseline and after treatment with LEV were 67 and 44, respectively. The statistical analysis confirmed a significant improvement with a p-value of <0.001 on the YGTSS and MCGI. In 3 cases, treatment was suspended due to adverse effects.
CONCLUSIONS:
Treatment with LEV can constitute a treatment option for tics in patients with TS. Double-blind trials of longer duration are needed in larger samples in order to establish both the benefit, as well as what patients are eligible for treatment.
AuthorsAlberto Fernández-Jaén, Daniel Martín Fernández-Mayoralas, Nuria Muñoz-Jareño, Beatriz Calleja-Pérez
JournalEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society (Eur J Paediatr Neurol) Vol. 13 Issue 6 Pg. 541-5 (Nov 2009) ISSN: 1532-2130 [Electronic] England
PMID19211282 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Nootropic Agents
  • Levetiracetam
  • Piracetam
Topics
  • Adolescent
  • Child
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Levetiracetam
  • Male
  • Nootropic Agents (therapeutic use)
  • Piracetam (analogs & derivatives, therapeutic use)
  • Prospective Studies
  • Psychiatric Status Rating Scales
  • Severity of Illness Index
  • Tourette Syndrome (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: